Financial results for the quarter and year ended as on 31.03.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.6 pts less than Nifty Microcap 250 and 7.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vasundhara Rasayans Limited reported a decline in full-year performance for FY25. Net sales fell to Rs 3,399.01 lakhs from Rs 3,701.84 lakhs in FY24, an 8.2% drop, while net profit after tax declined sharply to Rs 424.63 lakhs from Rs 585.93 lakhs, a fall of about 27.5%. Profit before tax also slipped to Rs 576.73 lakhs (vs Rs 789.50 lakhs). EPS for the year came in at Rs 13.39 versus Rs 18.44 previously. The standalone results carry an unmodified audit opinion from statutory auditors M/s Mamta Jain & Associates, and the company operates in a single segment — agri products. Borrowings more than doubled to Rs 420.61 lakhs and loans extended by the company jumped to Rs 2,446 lakhs.
Despite reporting positive profits and a clean audit, shareholders should note weakening top-line, shrinking margins, and a sharply negative operating cash flow of Rs (583.46) lakhs compared to Rs 602.99 lakhs last year — a red flag that core business is not generating cash. Rising borrowings and large loans extended may pressure liquidity and returns going forward.